About Asklepios Remedies
About Our Pharma Company - Asklepios Remedies
The Company Asklepios Remedies (P) Ltd. was established by a team of technically qualified persons in 1989 with the objective to produce quality medicines and hence the name of the company is ASKLEPIOS. (“The GOD of Medicine of ancient Greece from where arose the international symbols of pharmacy and medicine still used today”.)
The founding Chairman & Managing Director of the Company – Late Nand Kishore Prasad was a B.Pharm. and M.B.A. He himself was a well experienced man having more than thirty five years of experience in manufacturing and marketing of pharmaceutical products. He might be no more between us but his mission "to provide quality medicines at economical and affordable price for all" is maintained till now.
"His life was blessing, his memory a treasure.
He is loved beyond words and missed beyond measure"
Present Chairman & Managing Director of the company Mr. Shashikant Kumar (Sanjay) is also B.Pharm. He is also technically qualified and have more than twenty years of experience in the manufacturing and quality control of pharmaceutical products.
Besides, the Assitt. Mfg. Chemists, Assitt. QC Chemists and the Quality Assurance Chemist are also technically qualified. They all are B.Pharm./M.Sc. (Chemistry) and are having long experience in their specialization.In its small span of time, The Company has gained a good reputation for quality medicines in the market and has also been awarded by many departments of the government.
The company is an ISO 9001:2000 and 9001:2008 certified company since last more than ten years.
The company is also State GMP certified since last ten years.
Significance
Asklepios is considered the ideal physician and the challenges he or she may face.
Symbolism
The rod of Asclepius, a staff with a snake wrapped around it, is still a symbol of medicine today.
Research & Development (R&D)
Asklepios Remedies proceeds with Research adn then development of its medicines to make it available and effective for its end users.
